Use of a long-acting inhaled β2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease

S. I. Rennard, W. Anderson, R. ZuWallack, J. Broughton, W. Bailey, M. Friedman, M. Wisniewski, K. Rickard

Research output: Contribution to journalArticlepeer-review

240 Scopus citations

Fingerprint Dive into the research topics of 'Use of a long-acting inhaled β<sub>2</sub>-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease'. Together they form a unique fingerprint.

Medicine & Life Sciences